Open AccessAbstract 2893: ALK amplification and rearrangements are recurrent targetable events in glioblastoma
Author(s) -
Anne-Florence Blandin
Publication year - 2019
Publication title -
tumor biology
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1423-0380
pISSN - 1010-4283
DOI - 10.1158/1538-7445.sabcs18-2893
Subject(s) - crizotinib , anaplastic lymphoma kinase , cancer research , immunohistochemistry , biology , alk inhibitor , glioma , microbiology and biotechnology , medicine , lung cancer , pathology , immunology , malignant pleural effusion